PETER HARPER, Guy’s Hospital, London
REFERENCE: “Management of Tumour and Treatment Related Symptoms” section, Perspectives in Lung Cancer, Seville
Bisphosphonates may be more suited for improving the outlook among patients with lung cancer who have bone metastases compared to palliative radiation and analgesics, according to Peter Harper, who assessed the data from recent studies for delegates at the Lung Cancer conference in Seville. He talked with Peter Goodwin.
Bisphosphonates may be more suited for improving the outlook among patients with lung cancer who have bone metastases compared to palliative radiation and analgesics, according to Peter Harper, who assessed the data from recent studies for delegates at the Lung Cancer conference in Seville. He talked with Peter Goodwin.
To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.
